Risk biomarkers. Intervention trials. Health disparities. Policy and regulation.

From epidemiology and laboratory research to social sciences and community outreach, the scientists in Roswell Park’s Department of Cancer Prevention & Control (CPC) explore the cause and progression of common cancers, and develop intervention programs for at-risk communities.

Landmark Research

Roswell Park has been conducting prominent epidemiological research for more than half a century, dating back to a groundbreaking landmark paper in JAMA published in 1950 on Cancer and Tobacco Smoking – one of the first to link cigarette smoking to lung cancer.

What we do

CPC research at Roswell Park ranges from conducting population-based molecular epidemiology studies to intervention studies in cancer patients and survivors to improve cancer outcomes.

Some of our current investigations include:

  • The role of gene-environment interactions in cancer etiology and prognosis, with ongoing research in cancers of the ovary, breast, lung, head and neck, esophagus, prostate and bladder.
  • Breast cancer disparities to better understand the reasons for more aggressive breast cancer in Black women.
  • Cancer health equity in African American, Hispanic and Native American populations.

Our innovative intervention studies examine the effectiveness of behavioral strategies to prevent cancer and cancer recurrence, particularly dietary and weight loss interventions for the primary prevention of cancer. We focus on translating evidence-based intervention strategies for diverse communities using an implementation science framework.

Leonard Medico, Research Technologist

Spotlight: Data Bank and Biorepository

For more than 15 years, Roswell Park patients, their families and friends have helped build one of the most powerful tools available to cancer researchers — the Data Bank and BioRepository (DBBR).

It contains biological samples plus medical and health behavior information from more than 35,000 people, including 23,000 Roswell Park patients and 4,800 people who have never had cancer. Its power continues to grow with the addition of new samples and data.

Why is it so valuable? The information it contains can help scientists zero in on some of the biological differences between people who have cancer and people who don’t. Identifying those differences could lead to better tests for early detection of cancer and more effective cancer treatments.

Read more: Unlocking Cancer’s Mysteries at Roswell Park

Visit the DBBR

Training the next generation of scientists

In addition to our research and community outreach, the Department of Cancer Prevention & Control is actively involved in hands-on teaching with Master’s and PhD students in our highly competitive graduate studies program.

Our multidisciplinary education model allows students a unique immersive experience, preparing them for successful careers as independent investigators. 

Cancer Prevention Seminar Series

Spotlight: Seminar Series

Cancer Prevention & Control invites leading experts in the fields of epidemiology, genetics, cancer biology, sociology and psychology to provide weekly Grand Rounds presentations.

Robust team of experts

The Department of Cancer Prevention & Control currently has 18 full-time faculty, three distinguished emeritus faculty, and four adjunct faculty.

Specializing In: Molecular genetics factors that influence cancer treatment outcomes.

Research interests: Risk factors for aggressive breast tumor characteristics in African-American women; using molecular epidemiology, with biomarkers of susceptibility and exposure, to elucidate cancer etiology; examining genetic and modifiable factors that influence cancer treatment outcomes.

Contact us

Gregory L. Ciupak, MPH
Senior Department Administrator
Phone: 716-845-8863
FAX: 716-845-8487